水腎症の世界市場レポート 2025年

水腎症の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.2％で49億9,000万米ドルに成長すると予想されます。予測期間の成長は、慢性腎臓病の有病率の増加、低侵襲手術の採用率の上昇、早期発見に対する意識の高まり、ヘルスケアインフラの拡大、新しい治療オプションの開発に起因しています。予測期間における主な動向としては、個別化医療の拡大、診断における人工知能の利用の増加、非侵襲的治療法の進歩、患者中心のヘルスケアアプローチの台頭、腎臓学における遠隔医療の統合などが挙げられます。

腎臓病の有病率の増加は、今後の水腎症市場の成長を促進すると予想されます。腎臓病は、腎症とも呼ばれ、腎臓の損傷につながり、血液を効果的にろ過する能力を妨げるさまざまな状態を包含します。腎臓病患者の急増は、糖尿病や高血圧の増加、肥満、高齢化、遺伝的・民族的影響など複数の要因に起因しています。水腎症の治療は、尿閉の根本的な原因に対処することに重点を置いており、尿の流れを正常に戻すために、薬物療法、外科的処置、その他の介入を行うことがあります。例えば、英国を拠点とする非営利団体Kidney Research UKが2023年6月に発表した報告書によると、英国では現在約720万人が慢性腎臓病を患っており、人口の10％以上を占めています。このうち325万人が進行期で、さらに390万人が初期段階にあります。2033年までには、慢性腎臓病の患者数は761万人に増加すると予測されています。このように、腎臓病の罹患率の上昇が水腎症市場の成長を促進しています。

水腎症市場の主要企業は、ドレナージカテーテルのような革新的な製品を開発し、腎臓からの尿排出のための効率的で低侵襲なソリューションを提供することで、患者のケアを改善しています。ドレナージカテーテルは、体内の圧力を緩和したり体液の蓄積を防ぐために、尿や血液などの体液を体外に排出するように設計された医療機器です。例えば、2024年10月、米国を拠点とする特殊医療製品メーカーであるArgon Medical Devices Inc.は、SKATERミニループ排液カテーテルを発表しました。この装置は、体内の不要な体液を低侵襲で排出するために特別に設計されています。画像ガイダンスを用いて皮膚から挿入し、ループを40％小さくすることで、より小さな腔からの確実な留置と効果的なドレナージを可能にしています。耐久性、耐キンク性、アルコール適合性で有名なこのカテーテルは、介入的措置中の使いやすさを向上させます。Argonのドレナージ製品ラインを拡大することで、SKATERミニループは患者の予後を改善し、ヘルスケア専門家のドレナージプロセスを合理化することを目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の水腎症市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の水腎症市場：成長率分析
• 世界の水腎症市場の実績：規模と成長、2019～2024年
• 世界の水腎症市場の予測：規模と成長、2024～2029年、2034年
• 世界の水腎症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の水腎症市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 片側性水腎症
• 両側性水腎症
• 世界の水腎症市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• 内因性
• 外因性
• 世界の水腎症市場：診断別、実績と予測、2019～2024年、2024～2029年、2034年
• 臨床検査
• 画像診断
• 世界の水腎症市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 衝撃波結石破砕術
• 腹腔鏡検査
• 膀胱カテーテル挿入
• ステロイド療法
• その他
• 世界の水腎症市場：片側性水腎症のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 先天性片側性水腎症
• 後天性片側性水腎症
• 閉塞性片側性水腎症
• 非閉塞性片側性水腎症
• 世界の水腎症市場：両側性水腎症のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 先天性両側性水腎症
• 後天性両側性水腎症
• 閉塞性両側性水腎症
• 非閉塞性両側性水腎症

第7章 地域別・国別分析

• 世界の水腎症市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の水腎症市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 水腎症市場：競合情勢
• 水腎症市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • M Company Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medtronic PLC
• Amgen Inc.
• Stryker Corporation
• Thermo Fisher Scientific Inc.
• B. Braun Group
• Terumo Interventional Systems
• Sigma-Aldrich Co
• Coloplast A/S
• Cook Medical
• KARL STORZ SE & Co. KG
• Spire Healthcare Group plc
• Promega Corporation
• NantHealth Inc.
• UroGen Pharma Ltd.
• Natus Medical Incorporated

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 水腎症市場2029：新たな機会を提供する国
• 水腎症市場2029：新たな機会を提供するセグメント
• 水腎症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hydronephrosis is a medical condition marked by the swelling of one or both kidneys due to a buildup of urine. This swelling happens when urine flow is obstructed, leading to an enlarged kidney. The obstruction can be caused by factors such as kidney stones, tumors, or anatomical abnormalities, and if not treated, it may result in kidney damage.

Hydronephrosis can be classified into two main types such as unilateral and bilateral. Unilateral hydronephrosis occurs when one kidney swells due to a blockage or other issues in the urinary tract on that side. It can be further categorized as intrinsic or extrinsic. Diagnosis typically involves laboratory tests and imaging studies. Treatment options may include shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, among others.

The hydronephrosis market research report is one of a series of new reports from The Business Research Company that provides hydronephrosis market statistics, including hydronephrosis industry global market size, regional shares, competitors with a hydronephrosis market share, detailed hydronephrosis market segments, market trends and opportunities, and any further data you may need to thrive in the hydronephrosis industry. This hydronephrosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hydronephrosis market size has grown rapidly in recent years. It will grow from $3.06 billion in 2024 to $3.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the increasing prevalence of kidney stones, rising incidence of urinary tract infections, growth in the geriatric population, increasing awareness and early diagnosis, and rising healthcare expenditure.

The hydronephrosis market size is expected to see rapid growth in the next few years. It will grow to $4.99 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the increasing prevalence of chronic kidney diseases, rising adoption of minimally invasive surgeries, growing awareness about early detection, expansion of healthcare infrastructure, and development of new treatment options. Major trends in the forecast period include growth in personalized medicine, increasing use of artificial intelligence in diagnostics, advancements in non-invasive treatment methods, rise in patient-centric healthcare approaches, and integration of telemedicine in nephrology.

The increasing prevalence of kidney diseases is anticipated to drive the growth of the hydronephrosis market in the future. Kidney disease, also referred to as renal disease or nephropathy, encompasses a variety of conditions that lead to kidney damage, hindering their ability to effectively filter blood. The surge in kidney disease cases can be attributed to multiple factors, including the growing rates of diabetes and hypertension, obesity, an aging population, and both genetic and ethnic influences. Treatment for hydronephrosis focuses on addressing the underlying causes of urinary obstruction, which may involve medications, surgical procedures, or other interventions to restore normal urine flow. For example, a report published in June 2023 by Kidney Research UK, a non-profit organization based in the UK, indicated that approximately 7.2 million people in the UK are currently living with chronic kidney disease, accounting for over 10% of the population. Among these individuals, 3.25 million are in the advanced stages of the disease, while another 3.9 million are in the early stages. By 2033, it is projected that the number of individuals affected by chronic kidney disease will increase to 7.61 million. Thus, the rising incidence of kidney diseases is fueling the growth of the hydronephrosis market.

Leading companies in the hydronephrosis market are creating innovative products like drainage catheters to improve patient care by offering efficient and minimally invasive solutions for urine drainage from the kidneys. Drainage catheters are medical devices designed to extract fluids, such as urine or blood, from the body to alleviate pressure or prevent fluid buildup. For example, in October 2024, Argon Medical Devices Inc., a U.S.-based manufacturer of specialized medical products, introduced the SKATER mini-loop drainage catheter. This device is specifically designed for the minimally invasive drainage of unwanted fluid collections within the body. It is inserted through the skin with imaging guidance and features a loop that is 40% smaller, ensuring secure placement and effective drainage from smaller cavities. Renowned for its durability, kink resistance, and compatibility with alcohol, this catheter enhances usability during interventional procedures. By expanding Argon's drainage product line, the SKATER Mini-Loop aims to improve patient outcomes and streamline the drainage process for healthcare professionals.

In October 2023, Laborie Medical Technologies Corp., a US-based diagnostic company, acquired Urotronic Inc. for an undisclosed amount. This acquisition strengthens Laborie's urology portfolio by providing innovative solutions to physicians and patients worldwide. It allows Laborie to advance cutting-edge technologies to address unmet medical needs and deliver solutions that uphold and restore human dignity. Urotronic Inc., a US-based medical device company, specializes in developing innovative treatments for urological conditions.

Major companies operating in the hydronephrosis market are AbbVie Inc., Boston Scientific Corporation, Novartis AG, 3M Company, F. Hoffmann-La Roche Ltd, Medtronic PLC, Amgen Inc., Stryker Corporation, Thermo Fisher Scientific Inc., B. Braun Group, Terumo Interventional Systems, Sigma-Aldrich Co, Coloplast A/S, Cook Medical, KARL STORZ SE & Co. KG, Spire Healthcare Group plc, Promega Corporation, NantHealth Inc., UroGen Pharma Ltd., Natus Medical Incorporated, Renal Associates P.A., Urologix Inc., Savant Medical Group

North America was the largest region in the hydronephrosis market in 2024. The regions covered in the hydronephrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hydronephrosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hydronephrosis market includes revenues earned by entities by providing services such as urine flow monitoring, follow-up care, and minimally invasive procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hydronephrosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hydronephrosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hydronephrosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hydronephrosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Unilateral Hydronephrosis; Bilateral Hydronephrosis
• 2) By Indication: Intrinsic; Extrinsic
• 3) By Diagnosis: Laboratory Test; Imaging
• 4) By Treatment: Shock Wave Lithotripsy; Laparoscopy; Bladder Catheterization; Steroid Therapy; Other Treatments
• Subsegments:
• 1) By Unilateral Hydronephrosis: Congenital Unilateral Hydronephrosis; Acquired Unilateral Hydronephrosis; Obstructive Unilateral Hydronephrosis; Non-Obstructive Unilateral Hydronephrosis
• 2) By Bilateral Hydronephrosis: Congenital Bilateral Hydronephrosis; Acquired Bilateral Hydronephrosis; Obstructive Bilateral Hydronephrosis; Non-Obstructive Bilateral Hydronephrosis
• Companies Mentioned: AbbVie Inc.; Boston Scientific Corporation; Novartis AG; 3M Company; F. Hoffmann-La Roche Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hydronephrosis Market Characteristics

3. Hydronephrosis Market Trends And Strategies

4. Hydronephrosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hydronephrosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hydronephrosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hydronephrosis Market Growth Rate Analysis
• 5.4. Global Hydronephrosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hydronephrosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hydronephrosis Total Addressable Market (TAM)

6. Hydronephrosis Market Segmentation

• 6.1. Global Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Unilateral Hydronephrosis
• Bilateral Hydronephrosis
• 6.2. Global Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intrinsic
• Extrinsic
• 6.3. Global Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Test
• Imaging
• 6.4. Global Hydronephrosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Shock Wave Lithotripsy
• Laparoscopy
• Bladder Catheterization
• Steroid Therapy
• Other Treatments
• 6.5. Global Hydronephrosis Market, Sub-Segmentation Of Unilateral Hydronephrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Congenital Unilateral Hydronephrosis
• Acquired Unilateral Hydronephrosis
• Obstructive Unilateral Hydronephrosis
• Non-Obstructive Unilateral Hydronephrosis
• 6.6. Global Hydronephrosis Market, Sub-Segmentation Of Bilateral Hydronephrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Congenital Bilateral Hydronephrosis
• Acquired Bilateral Hydronephrosis
• Obstructive Bilateral Hydronephrosis
• Non-Obstructive Bilateral Hydronephrosis

7. Hydronephrosis Market Regional And Country Analysis

• 7.1. Global Hydronephrosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hydronephrosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hydronephrosis Market

• 8.1. Asia-Pacific Hydronephrosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hydronephrosis Market

• 9.1. China Hydronephrosis Market Overview
• 9.2. China Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hydronephrosis Market

• 10.1. India Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hydronephrosis Market

• 11.1. Japan Hydronephrosis Market Overview
• 11.2. Japan Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hydronephrosis Market

• 12.1. Australia Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hydronephrosis Market

• 13.1. Indonesia Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hydronephrosis Market

• 14.1. South Korea Hydronephrosis Market Overview
• 14.2. South Korea Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hydronephrosis Market

• 15.1. Western Europe Hydronephrosis Market Overview
• 15.2. Western Europe Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hydronephrosis Market

• 16.1. UK Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hydronephrosis Market

• 17.1. Germany Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hydronephrosis Market

• 18.1. France Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hydronephrosis Market

• 19.1. Italy Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hydronephrosis Market

• 20.1. Spain Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hydronephrosis Market

• 21.1. Eastern Europe Hydronephrosis Market Overview
• 21.2. Eastern Europe Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hydronephrosis Market

• 22.1. Russia Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hydronephrosis Market

• 23.1. North America Hydronephrosis Market Overview
• 23.2. North America Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hydronephrosis Market

• 24.1. USA Hydronephrosis Market Overview
• 24.2. USA Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hydronephrosis Market

• 25.1. Canada Hydronephrosis Market Overview
• 25.2. Canada Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hydronephrosis Market

• 26.1. South America Hydronephrosis Market Overview
• 26.2. South America Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hydronephrosis Market

• 27.1. Brazil Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hydronephrosis Market

• 28.1. Middle East Hydronephrosis Market Overview
• 28.2. Middle East Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hydronephrosis Market

• 29.1. Africa Hydronephrosis Market Overview
• 29.2. Africa Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hydronephrosis Market Competitive Landscape And Company Profiles

• 30.1. Hydronephrosis Market Competitive Landscape
• 30.2. Hydronephrosis Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4.3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Hydronephrosis Market Other Major And Innovative Companies

• 31.1. Medtronic PLC
• 31.2. Amgen Inc.
• 31.3. Stryker Corporation
• 31.4. Thermo Fisher Scientific Inc.
• 31.5. B. Braun Group
• 31.6. Terumo Interventional Systems
• 31.7. Sigma-Aldrich Co
• 31.8. Coloplast A/S
• 31.9. Cook Medical
• 31.10. KARL STORZ SE & Co. KG
• 31.11. Spire Healthcare Group plc
• 31.12. Promega Corporation
• 31.13. NantHealth Inc.
• 31.14. UroGen Pharma Ltd.
• 31.15. Natus Medical Incorporated

32. Global Hydronephrosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hydronephrosis Market

34. Recent Developments In The Hydronephrosis Market

35. Hydronephrosis Market High Potential Countries, Segments and Strategies

• 35.1 Hydronephrosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hydronephrosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hydronephrosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33493_Hydronephrosis_GMR_2025